ArticleEnvironment international2026
Prenatal exposure to particulate matter impairs offspring behavior via hippocampal NMDA receptor reduction: an in vivo and ex vivo study.
Article in Environment international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Accumulating epidemiological and experimental evidence implicates environmental particulate matter (PM) exposure as a risk factor for neurodevelopmental and neurodegenerative disorders. Because the developing brain is highly vulnerable to environmental toxicants, PM exposure during early pregnancy can exert disproportionate toxicity in offspring. However, systemic physiological effects of PM exposure can complicate the interpretation of neuron-specific susceptibility, and the susceptible brain cell types and molecular mechanisms underlying PM-induced neurotoxicity remain unclear. Here, we addressed this gap by investigating the neurotoxicity of PM exposure with a focus on specific brain cell populations. Prenatal intranasal administration of urban PM (200 and 400 μg/kg) induced abnormal offspring behaviors, including cognitive deficits, hyperactivity, and anxiety. Notably, exposure to 200 μg/kg PM elicited neurobehavioral abnormalities without affecting development or lung function. Transcriptomic analyses showed that PM altered hippocampal gene expression related to neuronal development and synaptic organization, potentially contributing to these behavioral deficits. Furthermore, PM reduced hippocampal expression of N-methyl-D-aspartate (NMDA) receptors, key glutamatergic receptors essential for neuronal development and function. Ex vivo hippocampal neuron cultures demonstrated that prenatal PM exposure (200 μg/kg) reduced NMDA receptor expression and disrupted spontaneous neuronal activity and synaptic networks, as revealed by imaging of pHluorin-tagged NMDA receptor subunits and electrophysiological recordings. By contrast, glial inflammatory responses remained unchanged. These adverse effects were recapitulated by prenatal exposure to benzo[a]pyrene (BaP), one of the most toxic polycyclic aromatic hydrocarbons in PM. Importantly, application of NMDA restored aberrant neuronal activity in PM- and BaP-exposed neurons. Our findings demonstrate the heightened vulnerability of the developing brain to PM exposure and underscore the need for effective strategies to mitigate PM-induced neurotoxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.